These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34501293)

  • 1. Sclerotherapy on Demand with Polidocanol to Treat HHT Nosebleeds.
    Marcos S; Botella LM; Albiñana V; Arbia A; de Rosales AM
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerotherapy and Topical Nasal Propranolol: An Effective and Safe Therapy for HHT-Epistaxis.
    Esteban-Casado S; Martín de Rosales Cabrera AM; Usarralde Pérez A; Martínez Simón JJ; Zhan Zhou E; Marcos Salazar MS; Pérez Encinas M; Botella Cubells L
    Laryngoscope; 2019 Oct; 129(10):2216-2223. PubMed ID: 30908653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT).
    Zarrabeitia R; Fariñas-Álvarez C; Santibáñez M; Señaris B; Fontalba A; Botella LM; Parra JA
    Health Qual Life Outcomes; 2017 Jan; 15(1):19. PubMed ID: 28114930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerotherapy for Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review.
    Thiele B; Abdel-Aty Y; Marks L; Lal D; Marino M
    Ann Otol Rhinol Laryngol; 2023 Jan; 132(1):82-90. PubMed ID: 35152768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia.
    Merlo CA; Yin LX; Hoag JB; Mitchell SE; Reh DD
    Int Forum Allergy Rhinol; 2014 Nov; 4(11):921-5. PubMed ID: 25145809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerotherapy Versus Cautery/Laser Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia.
    Woodard TD; Yappel-Sinkko KB; Wang X; McCrae KR; Parambil JG
    Laryngoscope; 2022 May; 132(5):920-925. PubMed ID: 34160081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia.
    Boyer H; Fernandes P; Le C; Yueh B
    Int Forum Allergy Rhinol; 2015 May; 5(5):435-40. PubMed ID: 25643928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of epistaxis severity score for hereditary hemorrhagic telangiectasia in Japan.
    Hayama M; Maeda Y; Shikina T; Tatehara S; Inokuchi G; Hoag JB; Sato T; Obata S; Nakatani A; Amano Y; Hida E; Nibu KI; Inohara H
    Auris Nasus Larynx; 2022 Jun; 49(3):415-420. PubMed ID: 34857410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the Psychometric Validity of the Epistaxis Severity Score: Internal Consistency and Test-Retest Reliability.
    Gong AJ; Bolsegui ML; Lee EE; Mathai SC; Weiss CR
    Am J Rhinol Allergy; 2024 Jan; 38(1):38-46. PubMed ID: 37822162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of endonasal HHT lesions using digital microscopy.
    Haubner F; Schneider A; Schinke H; Bertlich M; Weiss BG; Canis M; Kashani F
    Orphanet J Rare Dis; 2021 Apr; 16(1):182. PubMed ID: 33865423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal Efudix reduces epistaxis in hereditary hemorrhagic telangiectasia.
    de Jel DVC; Disch FJM; Kroon S; Mager JJ; Verdam FJ
    Angiogenesis; 2020 Aug; 23(3):271-274. PubMed ID: 32112177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal bevacizumab injections improve quality of life in HHT patients.
    Steineger J; Geirdal AØ; Osnes T; Heimdal KR; Dheyauldeen S
    Laryngoscope; 2020 May; 130(5):E284-E288. PubMed ID: 31287573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of nasal closure on quality of life in patients with hereditary hemorrhagic telangiectasia.
    Thomson RS; Molin NL; Whitehead KJ; Ashby S; Johnson L; Ward PD; McRae BR; Wilson KF; McDonald J
    Laryngoscope Investig Otolaryngol; 2018 Jun; 3(3):178-181. PubMed ID: 30062132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of bevacizumab on familial epistaxis caused by hereditary hemorrhagic telangiectasia].
    Zhang J; Wang XS; Wang HT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 May; 56(5):436-441. PubMed ID: 34010995
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of epistaxis in hereditary haemorrhagic telangiectasia (HHT) patients using pulsed dye laser and the effect of withholding treatment during the COVID pandemic.
    Jiang Y; Dennis SC; Brewin MP
    Lasers Med Sci; 2022 Oct; 37(8):3147-3153. PubMed ID: 35635649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Practice Guideline: Nosebleed (Epistaxis) Executive Summary.
    Tunkel DE; Anne S; Payne SC; Ishman SL; Rosenfeld RM; Abramson PJ; Alikhaani JD; Benoit MM; Bercovitz RS; Brown MD; Chernobilsky B; Feldstein DA; Hackell JM; Holbrook EH; Holdsworth SM; Lin KW; Lind MM; Poetker DM; Riley CA; Schneider JS; Seidman MD; Vadlamudi V; Valdez TA; Nnacheta LC; Monjur TM
    Otolaryngol Head Neck Surg; 2020 Jan; 162(1):8-25. PubMed ID: 31910122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FID Score: an effective tool in Hereditary Haemorrhagic Telangiectasia - related epistaxis.
    Pagella F; Maiorano E; Matti E; Tinelli C; De Silvestri A; Ugolini S; Lizzio R; Olivieri C; Pusateri A; Spinozzi G
    Rhinology; 2020 Oct; 58(5):516-521. PubMed ID: 32584331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
    Hanks JE; Hunter D; Goding GS; Boyer HC
    Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus as a Promising Drug for Epistaxis and Gastrointestinal Bleeding in HHT.
    Álvarez-Hernández P; Patier JL; Marcos S; Gómez Del Olmo V; Lorente-Herraiz L; Recio-Poveda L; Botella LM; Viteri-Noël A; Albiñana V
    J Clin Med; 2023 Nov; 12(23):. PubMed ID: 38068462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injection of bevacizumab and cyanoacrylate glue for hereditary hemorrhagic telangiectasia.
    Khoueir N; Borsik M; Camous D; Herman P; Verillaud B
    Laryngoscope; 2019 Oct; 129(10):2210-2215. PubMed ID: 31566760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.